跳至主要内容
临床试验/JPRN-UMIN000032557
JPRN-UMIN000032557已完成未知

An open-label continuation trial of tocilizumab for familial Mediterranean fever with colchicine ineffective or intolerance - An open-label continuation trial of tocilizumab for familial Mediterranean fever

Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences0 个研究点目标入组 24 人开始时间: 2018年5月30日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
12years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients applicable to even one of the following are excluded from the subject (1) Women who are breast-feeding, pregnant, or may become pregnant (2) Patients with a history of hypersensitivity to the components of tocilizumab (3) Patients whose corticosteroids are routinely used (excluding topical treatments such as external preparations) due to diseases other than familial Mediterranean fever and which are judged inappropriate by investigators or clinical trial doctors (4) Patients who have interstitial pneumonia and who are judged inappropriate by investigators or clinical trial doctors (5) Patients who have complicated serious diseases and who are judged inappropriate by investigators or clinical trial doctors as clinical trials (6) Patients whose investigator or clinical trial doctor judged that the condition in the preceding study is inappropriate for continued administration (7) Patients judged inappropriate by investigators or clinical trial doctors

研究者

发起方
Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences

相似试验